These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32411333)

  • 1. Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing.
    Uddin MS; Kabir MT; Jeandet P; Mathew B; Ashraf GM; Perveen A; Bin-Jumah MN; Mousa SA; Abdel-Daim MM
    Oxid Med Cell Longev; 2020; 2020():7039138. PubMed ID: 32411333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review.
    Yuksel M; Tacal O
    Eur J Pharmacol; 2019 Aug; 856():172415. PubMed ID: 31132354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular rationale for the pharmacological treatment of Alzheimer's disease.
    Zimmermann M; Gardoni F; Di Luca M
    Drugs Aging; 2005; 22 Suppl 1():27-37. PubMed ID: 16506440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Y
    Matrone C; Iannuzzi F; Annunziato L
    Ageing Res Rev; 2019 Jul; 52():120-128. PubMed ID: 31039414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APP processing in Alzheimer's disease.
    Zhang YW; Thompson R; Zhang H; Xu H
    Mol Brain; 2011 Jan; 4():3. PubMed ID: 21214928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease.
    Ling Y; Morgan K; Kalsheker N
    Int J Biochem Cell Biol; 2003 Nov; 35(11):1505-35. PubMed ID: 12824062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation Signaling in APP Processing in Alzheimer's Disease.
    Zhang T; Chen D; Lee TH
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of amyloid-β generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35.
    Chau DD; Yung KW; Chan WW; An Y; Hao Y; Chan HE; Ngo JC; Lau KF
    FASEB J; 2019 Nov; 33(11):12019-12035. PubMed ID: 31373844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer's Disease.
    Nagase H; Nakayama K
    Curr Drug Discov Technol; 2014; 11(4):243-58. PubMed ID: 25413946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking and processing: evidence for a role in Alzheimer's disease.
    Brodeur J; Thériault C; Lessard-Beaudoin M; Marcil A; Dahan S; Lavoie C
    Mol Neurodegener; 2012 Jun; 7():31. PubMed ID: 22734645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
    Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC
    J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease.
    Bandyopadhyay S; Goldstein LE; Lahiri DK; Rogers JT
    Curr Med Chem; 2007; 14(27):2848-64. PubMed ID: 18045131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-amyloid, neuronal death and Alzheimer's disease.
    Carter J; Lippa CF
    Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BACE1: the beta-secretase enzyme in Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascidians: an invertebrate chordate model to study Alzheimer's disease pathogenesis.
    Virata MJ; Zeller RW
    Dis Model Mech; 2010; 3(5-6):377-85. PubMed ID: 20197417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.